Original ArticleInternational Journal of Pharmaceutical InvestigationVol. 14 | Issue 2 | 2024 | pp. 472–481Open access
Development and Characterization of Moxifloxacin Hydrochloride Cubogel for Enhanced Ocular Drug Delivery
- 1,2*,
- 1
- 1 Department of Pharmaceutics, Mount Zion College of Pharmaceutical Sciences and Research, Chayalode, Ezhamkulam, Adoor, Pathanamthitta, Kerala, INDIA.
- 2 Department of Pharmaceutical Sciences, Shri Jagdishprasad Jhabarmal Tibrewala University, Vidyanagari, Churela, Rajasthan, INDIA.
Published in International Journal of Pharmaceutical Investigation
Correspondence: Bhageerathy Anantha Narayana Iyer
Department of Pharmaceutics, Mount Zion College of Pharmaceutical Sciences and Research, Chayalode, Ezhamkulam, Adoor, Pathanamthitta, Kerala, INDIA.; Department of Pharmaceutical Sciences, Shri Jagdishprasad Jhabarmal Tibrewala University, Vidyanagari, Churela, Rajasthan, INDIA.
Email: bhageerathyiyer@gmail.com
Copyright: © 2024 Manuscript Technomedia. This is an open access article.
- Published:
- Apr 2, 2024
- Received:
- Nov 14, 2023
- Accepted:
- Jan 6, 2024
- DOI:
- 10.5530/ijpi.14.2.57
How to cite
Iyer, B. A. N., & Vasantha, P. V. (2024). Development and Characterization of Moxifloxacin Hydrochloride Cubogel for Enhanced Ocular Drug Delivery. International Journal of Pharmaceutical Investigation, 14(2), 472–481. https://doi.org/10.5530/ijpi.14.2.57
Abstract
Purpose
The study aimed to formulate and evaluate an ocular effective prolonged release cubogel formulation of Moxifloxacin Hydrochloride (MX-Cubogel) to treat conjunctivitis.
Materials and Methods
Initially, a Moxifloxacin-loaded cubosome (MX-Cubosome) was prepared using a top-down technique using glyceryl monooleate and poloxamer 407 in different concentrations. The optimized MX-Cubosome was selected based on the physicochemical characteristics and was used to prepare MX-Cubogel by dispersing the cubosome into an in situ gelling system using the cold method. Physicochemical characterization, drug-polymer interaction studies, and histopathological studies were performed.
Results
Twelve MX-Cubosomal dispersions were prepared. The cubosomes were consistent, aggregate-free, and milky white. Particle sizes ranged from 306.5 to 714.2 nm, with a uniform size distribution. Zeta potentials were between -27.9 and -39.8 mv and encapsulation efficiencies ranged from 69% to 85%. Electron microscopy confirmed the nano-sized structure of the cubosomes. The MX-Cubogels were clear, with no visible impurities. Four formulations (MB11, MB12, MB15 and MB16) gelled immediately and remained stable over time. The gelation temperatures of the majority of formulations were between 28°C and 43°C. MX-Cubogels had a drug content of 92.5% to 97.7%. Four formulations (MB4, MB7, MB10 and MB13) released more than 95% of the drug over 12 hr. The antibacterial activity of the MX-Cubogels was demonstrated by an inhibition zone of 32 mm, which was greater than the standard (27 mm). Histological examination of goat corneas treated with selected formulations (MB4, MB7, MB10 and MB13) showed normal structures, with no changes in the epidermal layer after cubosomal formulation penetration.
Conclusion
The study demonstrates that MX-Cubosome dispersions can be successfully formulated as in situ gels (MX-Cubogel) with sustained release and antibacterial activity. The gels are also non-irritating to the cornea. MX-Cubogel might be a good alternative to conventional eye drops.
Keywords
Subject
Article metadata
| Title | Development and Characterization of Moxifloxacin Hydrochloride Cubogel for Enhanced Ocular Drug Delivery |
|---|---|
| Authors | Bhageerathy Anantha Narayana Iyer; Prasanth Viswanadhan Vasantha |
| Affiliations | Department of Pharmaceutics, Mount Zion College of Pharmaceutical Sciences and Research, Chayalode, Ezhamkulam, Adoor, Pathanamthitta, Kerala, INDIA.; Department of Pharmaceutical Sciences, Shri Jagdishprasad Jhabarmal Tibrewala University, Vidyanagari, Churela, Rajasthan, INDIA. |
| Corresponding author | bhageerathyiyer@gmail.com |
| Journal | International Journal of Pharmaceutical Investigation |
| Volume / Issue | Vol. 14, Issue 2 (2024) |
Also in this issue
- The Effect of Halotherapy in Chronic Respiratory Disease: An Adjunct to Physiotherapy-A Narrative Reviewpp. 268–272
- An Update on Medicinal Importance of the Plant: Polygonum plebeium R. Br.pp. 273–288
- Sulbactam and Durlobactam Combination as a Newer Antibiotic for Carbapenem-Resistant Acinetobacter baumannii Infectionspp. 289–298
- Impurities in Drug Substance-An Overview of ICH Q3A, Q3C and M7 Guidelinespp. 299–305
- Harmonised Methods for Detection of Insulin Immunogenicitypp. 306–316
Readers Also Viewed
Development and Validation of UV/visible Spectrophotometric Method for Estimation of Piroxicam from Bulk and Formulation
Sandip Mohan Honmane, Kunal Rajaram Yadav, Yuvraj Dilip Dange
Apr 23, 2025
Effects of Artificial Intelligence on Academic Performance of Library and Information Science University Students: A Meta-Analysis (2023-2025)
Kayode Sunday John Dada
Aug 6, 2026
Bridging Innovation and Impact: A Multidisciplinary Approach to Contemporary Research Challenges
Mueen Ahmed KK
Aug 11, 2026